Whole genomes redefine the mutational landscape of pancreatic cancer.

Nature 2015 Feb;518(7540):495-501

1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia [2] Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We performed whole-genome sequencing and copy number variation (CNV) analysis of 100 pancreatic ductal adenocarcinomas (PDACs). Chromosomal rearrangements leading to gene disruption were prevalent, affecting genes known to be important in pancreatic cancer (TP53, SMAD4, CDKN2A, ARID1A and ROBO2) and new candidate drivers of pancreatic carcinogenesis (KDM6A and PREX2). Patterns of structural variation (variation in chromosomal structure) classified PDACs into 4 subtypes with potential clinical utility: the subtypes were termed stable, locally rearranged, scattered and unstable. A significant proportion harboured focal amplifications, many of which contained druggable oncogenes (ERBB2, MET, FGFR1, CDK6, PIK3R3 and PIK3CA), but at low individual patient prevalence. Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency. Of 8 patients who received platinum therapy, 4 of 5 individuals with these measures of defective DNA maintenance responded.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523082PMC
February 2015
184 Reads

Publication Analysis

Top Keywords

pancreatic cancer
12
dna maintenance
8
pancreatic
5
brca1 brca2
4
pancreatic carcinogenesis
4
candidate drivers
4
robo2 candidate
4
low individual
4
drivers pancreatic
4
carcinogenesis kdm6a
4
prex2 patterns
4
maintenance genes
4
kdm6a prex2
4
genes brca1
4
brca2 palb2
4
amplifications contained
4
palb2 mutational
4
contained druggable
4
cancer tp53
4
genes pancreatic
4

References

(Supplied by CrossRef)

NJ Vogelzang et al.
J. Clin. Oncol. 2012

AV Biankin et al.
Nature 2012

S Jones et al.
Science 2008

T Harada et al.
Oncogene 2008

PJ Stephens et al.
Cell 2011

PJ Stephens et al.
Nature 2009

CA Griffin et al.
Cancer Res. 1995

JJ Molenaar et al.
Nature 2012

PJ Campbell et al.
Nature 2010

T Conroy et al.
N. Engl. J. Med. 2011

A Sultana et al.
J. Clin. Oncol. 2007

Similar Publications